Abstract
The calcitonin (CT) concentration has been determined in the serum of 17 patients with different pituitary diseases. More or less elevated levels were found in 7 of them. No definite correlation has been observed between the immunoreactive CT and the different pituitary hormones.
References
Deftos L.J., Burton D., Catherwood B.D., Bone H.G., Parthermore J.G., Guillemin R., Watkins W.B., Moore R.Y. Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary. J. Clin. Endocrinol. Metab. 47: 457, 1978.
Heynen G., Franchimont P. Human calcitonin radioimmunoassay in normal and pathological conditions. Eur. J. Clin. Invest. 4: 213, 1974.
Bell N.H. Further studies on regulation of calcitonin release in vitro. Horm. Metab. Res. 7: 77, 1975.
Carman J.S., Wyatt R.J. Reduction of serum prolactin after subcutaneous salmon calcitonin. Lancet 1: 1267, 1977.
Stevenson J.C., Evans I.M.A., Colstone K.W., Gwee H.M., Mashiter K. Serum prolactin after subcutaneous human calcitonin. Lancet 2: 711, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ziliotto, D., Luisetto, G., Cecchini, M. et al. Calcitonin serum levels in different pituitary diseases. A preliminary report. J Endocrinol Invest 3, 71–72 (1980). https://doi.org/10.1007/BF03348221
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348221